Glypican-3 immunohistochemistry in the ovary

Histopathology

Volumn 53, Issue 1, 2008, Pages 115-117

  Pantanowitz, L ^a   Otis, C N ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYPICAN 3;

CHORIOCARCINOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DYSGERMINOMA; EMBRYONAL CARCINOMA; ENDOMETRIOID CARCINOMA; FEMALE; FETUS; FETUS DEVELOPMENT; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MIXED MULLERIAN TUMOR; OVARY DEVELOPMENT; OVARY TUMOR; PRIORITY JOURNAL; TERATOMA; YOLK SAC TUMOR;

FEMALE; GLYPICANS; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; OVARIECTOMY; OVARY; PILOT PROJECTS;

EID: 45549090040     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03045.x     Document Type: Letter

References (5)

1. Lin H, Huber R, Schlessinger D, Morin PJ. Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res. 1999 59 807 810.
2. Pilia G, Hughes-Benzie RM, MacKenzie A et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 1996 12 241 247.
3. Kandil D, Leiman G, Allegretta M et al. Glypican-3 immunocytochemistry in liver fine-needle aspirates: a novel stain to assist in the differentiation of benign and malignant liver lesions. Cancer 2007 111 316 322.
4. Zynger DL, Dimov ND, Luan C, Teh BT, Yang XJ. Glypican 3: a novel marker in testicular germ cell tumors. Am. J. Surg. Pathol. 2006 30 1570 1575.
5. Ota S, Hishinuma M, Yamauchi N et al. Oncofetal protein glypican-3 in testicular germ-cell tumor. Virchows Arch. 2006 449 308 314.